✦ LIBER ✦

Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer)

✍ Scribed by J.-P. MecKlin; H. J. Järvinen

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 369 KB
Volume: 68
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19910901)68:5<1109::aid-cncr2820680535>3.0.co;2-s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemoprevention in hereditary colorectal

Chemoprevention in hereditary colorectal cancer syndromes

✍ Ernest Hawk; Ron Lubet; Paul Limburg 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

Understanding of the neoplastic events involved in heritable colorectal cancer syndromes is increasing at the molecular and clinical levels. This knowledge is foundational to cancer chemoprevention, which attempts to inhibit or reverse the tumorigenic process through pharmacologic interventions appl

Clinical manifestations in patients with

Clinical manifestations in patients with hereditary nonpolyposis colorectal cancer

✍ Tomoda, Hirotsugu; Baba, Hideo; Oshiro, Tatsuo 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB 👁 1 views

The clinical manifestations of 1,042 Japanese patients with nonpolyposis colorectal cancer who underwent a resection between 1972 and 1992 at the National Kyushu Cancer Center were examined. Hereditary nonpolyposis colorectal cancer (HNPCC) was found in 39 (3.7%) patients. Some characteristic findin

Evaluation of enzymatic mutation detecti

Evaluation of enzymatic mutation detection™ in hereditary nonpolyposis colorectal cancer

✍ Robyn Otway; Natasha Tetlow; June Hornby; Maija Kohonen-Corish 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB 👁 1 views

In hereditary nonpolyposis colorectal cancer (HNPCC), the majority of reported mutations are dispersed throughout the 35 exons of the two principal susceptibility genes, MLH1 and MSH2, and because of this complexity, rapid mutation screening methods are required. The aim of this study was to evaluat

Clinical challenges in management of fam

Clinical challenges in management of familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer

✍ Patrick M. Lynch 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

A s of 1999, it is possible to test selected subjects for carriage of germline mutations in genes responsible for familial adenomatous polyposis (FAP), 1,2 hereditary nonpolyposis colorectal cancer (HNPCC), 3,4 Peutz-Jeghers syndrome, 5 and juvenile polyposis. 6,7 These diseases are heterogeneous ph

Prostate cancer is part of the hereditar

Prostate cancer is part of the hereditary non-polyposis colorectal cancer (HNPCC) tumor spectrum

✍ Claudio Soravia; Heleen van der Klift; Marie-Anne Bründler; Jean-Louis Blouin; J 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

Features of gastric cancer in hereditary

Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome

✍ Markku Aarnio; Reijo Salovaara; Lauri A. Aaltonen; Jukka-Pekka Mecklin; Heikki J 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 77 KB 👁 2 views

To identify characteristics of gastric cancer associated with hereditary non-polyposis colorectal cancer (HNPCC), we gathered clinical data and tumor samples relating to patients recorded in the Finnish HNPCC registry. Our series included 51 families with a characterized mutation and/or that met the